Developing the leading the treatment of adenoviral conjunctivitis
We are exclusively focused on developing the leading treatment of adenoviral conjunctivitis (also known as pink eye).
Our lead product candidate, OKG-0502, is a topical, eye drop formulation of an anti-viral medication with an ocular decongestant.
Information About this Condition